Tyra Biosciences Inc TYRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:21 PM EDT
10.82quote price arrow up+0.12 (+1.12%)
Volume
9,134
52 week range
4.93 - 31.36
Loading...
  • Open10.88
  • Day High10.88
  • Day Low10.01
  • Prev Close10.70
  • 52 Week High31.36
  • 52 Week High Date11/04/21
  • 52 Week Low4.93
  • 52 Week Low Date06/21/22

Key Stats

  • Market Cap454.12M
  • Shares Out41.97M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.1

KEY STATS

  • Open10.88
  • Day High10.88
  • Day Low10.01
  • Prev Close10.70
  • 52 Week High31.36
  • 52 Week High Date11/04/21
  • 52 Week Low4.93
  • 52 Week Low Date06/21/22
  • Market Cap454.12M
  • Shares Out41.97M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.1

RATIOS/PROFITABILITY

  • EPS (TTM)-1.61
  • P/E (TTM)-6.73
  • Fwd P/E (NTM)-7.49
  • EBITDA (TTM)-46.607M
  • ROE (TTM)-36.30%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tyra Biosciences Inc

There is no recent news for this security.

Profile

MORE
Tyra Biosciences, Inc. is a precision oncology company. The Company is focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. The Company uses its SNAP platform, which enables refinement of structural design through iterative molecular SNAPshots. The Company is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family, which are altered in approximately 7%...
Robert More
Non-Executive Chairman of the Board
Todd Harris Ph.D.
President, Chief Executive Officer, Treasurer, Director
Daniel Bensen
Chief Operating Officer
Esther Van Den Boom CPA
Chief Financial Officer
Robert Hudkins Ph.D.
Chief Technology Officer
Address
2656 State Street
Carlsbad, CA
92008
United States

Top Peers

SYMBOLLASTCHG%CHG
GLUE
Monte Rosa Therapeutics Inc
8.75+0.51+6.19%
ADGI
Adagio Therapeutics Inc
4.00+0.19+4.86%
LXRX
Lexicon Pharmaceuticals Inc
2.77+0.22+8.40%
BTAI
BioXcel Therapeutics Inc
14.98-0.37-2.44%
MRSN
Mersana Therapeutics Inc
7.93+0.93+13.29%